Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study


ARTAÇ M., Turha N. S., Kocer M., KARABULUT B., Bozcuk H., Yalcin S., ...Daha Fazla

TUMORI J, cilt.100, sa.2, ss.143-148, 2014 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 100 Sayı: 2
  • Basım Tarihi: 2014
  • Dergi Adı: TUMORI J
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.143-148
  • Anahtar Kelimeler: colon cancer, adjuvant therapy, prognostic factors, COLORECTAL-CANCER, FLUOROURACIL, OXALIPLATIN, LEUCOVORIN, THERAPY, SURVIVAL, OUTCOMES
  • Marmara Üniversitesi Adresli: Evet

Özet

Background. A high-risk group of patients with stage II colon cancer has been identified by the results of studies in Western populations. The aim of this study was to investigate the prognostic factors of adjuvant chemotherapy in Turkish patients with stage II colon cancer.